Belimumab CAS NO.356547-88-1

We provide customized and high-quality Belimumab product for your project.

Belimumab is a human monoclonal antibody that inhibits B lymphocyte stimulator (BLyS). Specific binding of belimumab with the soluble BLyS prevents the interaction of BLys with its three receptors and indirectly decreases the B-cell survival and production of autoantibodies. Belimumab has been approved for the treatment of systemic lupus erythematosus.